INFREQUENT LOSS OF HETEROZYGOSITY AND MUTATION OF THE P53 GENE IN IMMORTAL AND TRANSFORMED MOUSE EMBRYO FIBROBLASTS

被引:11
|
作者
TOKUMITSU, M [1 ]
KADOHAMA, T [1 ]
OGAWA, K [1 ]
机构
[1] ASAHIKAWA MED COLL,DEPT PATHOL,ASAHIKAWA 078,HOKKAIDO,JAPAN
关键词
P53 GENE POLYMORPHISM; MOUSE; IMMORTALIZATION; IN VITRO TRANSFORMATION; EMBRYONIC FIBROBLAST;
D O I
10.1002/mc.2940100109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Some of the progeny of isolated mouse embryo fibroblasts acquire the ability to grow indefinitely during cultivation, presumably through some mutational events. The relevance of p53 mutations and loss of heterozygosity to the mechanism of such immortal growth capability remains controversial. Since four bases in intron 1 of the p53 gene in C3H/HeJ mice are replaced by 13 different bases in DBA/2J mice, it is possible to distinguish maternal and paternal p53 alleles in the cells of F1 hybrids of these strains (C3D2F1) by electrophoresis of polymerase chain reaction fragments including the region. We established 23 spontaneously immortalized fibroblast cell lines from C3D2F1 mouse embryos and 29 transformed cell lines induced from one of the immortal cell lines, either by treatment with chemical carcinogens or by transfection with the c-Ha-ras gene. Of these 52 cell lines, only one, derived from fibroblasts unpassaged for 4 mo, showed p53 gene loss of heterozygosity and a structural alteration in the remaining allele. Our results demonstrated that p53 mutations are not a strict requirement for immortalization and transformation of mouse embryo fibroblasts in vitro. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 50 条
  • [21] LOSS OF HETEROZYGOSITY OF P53 TUMOR SUPPRESSOR GENE IN OVARIAN-CARCINOMA
    HAEFNER, H
    ROBERTS, J
    WILSON, M
    HUBBELL, G
    FRANK, TS
    LABORATORY INVESTIGATION, 1992, 66 (01) : A64 - A64
  • [22] Loss of heterozygosity of p53 gene of oral cancer detected by exfoliative cytology
    Huang, MF
    Chang, YC
    Liao, PS
    Huang, TH
    Tsay, CH
    Chou, MY
    ORAL ONCOLOGY, 1999, 35 (03): : 296 - 301
  • [23] Loss of heterozygosity of p53 gene in gastic carcinoma in the region of easten Turkey
    Pirim, I
    Karaman, A
    Ikbal, M
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 89 - 89
  • [24] Mouse models for generating P53 gene mutation spectra
    Zielinski, B
    Liu, ZP
    Hollstein, M
    Hergenhahn, M
    Luo, JL
    TOXICOLOGY LETTERS, 2002, 134 (1-3) : 31 - 37
  • [25] HETEROGENEITY IN DISTRIBUTION AND CONTENT OF P53 IN SV40-TRANSFORMED MOUSE FIBROBLASTS
    DAVIS, D
    WYNFORDTHOMAS, D
    EXPERIMENTAL CELL RESEARCH, 1986, 166 (01) : 94 - 102
  • [26] p53 mutation is infrequent in clear cell carcinoma of the ovary
    Ho, ESC
    Lai, CR
    Hsieh, YT
    Chen, JT
    Lin, AJ
    Hung, MJ
    Liu, FS
    GYNECOLOGIC ONCOLOGY, 2001, 80 (02) : 189 - 193
  • [27] INFREQUENT P53 GENE-MUTATIONS IN MEDULLOBLASTOMAS
    SAYLORS, RL
    SIDRANSKY, D
    FRIEDMAN, HS
    BIGNER, SH
    BIGNER, DD
    VOGELSTEIN, B
    BRODEUR, GM
    CANCER RESEARCH, 1991, 51 (17) : 4721 - 4723
  • [28] Infrequent p53 gene alterations in ulcerative colitis
    Mattar, R
    Alexandrino, AM
    Laudanna, AA
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1999, 32 (09) : 1083 - 1088
  • [29] Telomeric repeat-length alterations in colorectal carcinoma are associated with loss of heterozygosity and point mutation in p53 gene
    Ohki, S
    Onda, M
    Fukushima, T
    Takita, K
    Suzuki, S
    Hoshino, M
    Tsuchiya, A
    Abe, R
    Takenoshita, S
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 11 (04) : 485 - 490
  • [30] Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene
    Liu, ZP
    Hergenhahn, M
    Schmeiser, HH
    Wogan, GN
    Hong, A
    Hollstein, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) : 2963 - 2968